Short interest in NewAmsterdam Pharma Co NV (NASDAQ:NAMS) increased during the last reporting period, rising from 548.71K to 718.04K. This put 1.29% of the company's publicly available shares short.

Short interest for NewAmsterdam Pharma gives investors a sense of the degree to which investors are betting on the decline of NewAmsterdam Pharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 195.79K shares traded per day, it would take 3.67 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.